55
Views
8
CrossRef citations to date
0
Altmetric
Original Research

The effect of environmental factors on the differential expression of miRNAs in patients with chronic obstructive pulmonary disease: a pilot clinical study

, , , , , , , & show all
Pages 741-751 | Published online: 28 Feb 2018

References

  • Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease Updated 2014. Available from: http://goldcopd.org/Accessed February 07, 2018
  • ZhongNWangCYaoWPrevalence of chronic obstructive pulmonary disease in China: a large, population-based surveyAm J Respir Crit Care Med2007176875376017575095
  • DonaldsonGCSeemungalTABhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax2002571084785212324669
  • DonaldsonGCWedzichaJACOPD exacerbations. 1: epidemiologyThorax200661216416816443707
  • SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
  • World Health OrganizationAmbient (outdoor) air quality and healthGenevaWorld Health Organization2014 Available from:http://www.who.int/mediacentre/factsheets/fs313/enAccessed February 07, 2018
  • LiuLBreitnerSPanXAssociations between air temperature and cardio-respiratory mortality in the urban area of Beijing, China: a time-series analysisEnviron Health2011105121612647
  • YangGWangYZengYRapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010Lancet201338198821987201523746901
  • RumanaHSSharmaRCBeniwalVSharmaAKA retrospective approach to assess human health risks associated with growing air pollution in urbanized area of Thar Desert, western Rajasthan, IndiaJ Environ Health Sci Eng20141212324406114
  • TsaiSSChangCCYangCYFine particulate air pollution and hospital admissions for chronic obstructive pulmonary disease: a case-crossover study in TaipeiInt J Environ Res Public Health201310116015602624284359
  • SchikowskiTAdamMMarconAAssociation of ambient air pollution with the prevalence and incidence of COPDEur Respir J201444361462624488569
  • BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell2004116228129714744438
  • OglesbyIKMcElvaneyNGGreeneCMMicroRNAs in Inflammatory lung disease – master regulators or target practice?Respir Res20101114821029443
  • MitchellPSParkinRKKrohEMCirculating microRNAs as stable blood-based markers for cancer detectionProc Natl Acad Sci U S A200810530105131051818663219
  • SongWJKwonJWKimEJClinical application of exhaled nitric oxide measurements in a Korean populationAllergy Asthma Immunol Res20157131325553257
  • American Thoracic SocietyEuropean Respiratory SocietyATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005Am J Respir Crit Care Med2005171891293015817806
  • YanPLinRJiaYInfluence of environmental factors on the migratory birds population with chronic obstructive pulmonary diseaseZhonghua Yi Xue Za Zhi2015953629242927 Chinese26814067
  • EzzieMECrawfordMChoJHGene expression networks in COPD: microRNA and MRNA regulationThorax201267212213121940491
  • MizunoSBogaardHJGomez-ArroyoJMicroRna-199a-5p is associated with hypoxia-inducible factor-1α expression in lungs from patients with COPDChest2012142366367222383663
  • SatoTLiuXNelsonAReduced miR-146a increases prostaglandin E2 in chronic obstructive pulmonary disease fibroblastsAm J Respir Crit Care Med201018281020102920522791
  • ChristensonSABrandsmaCACampbellJDmiR-638 regulates gene expression networks associated with emphysematous lung destructionGenome Med201351211424380442
  • ZengGSunBZhongNNon-smoking-related chronic obstructive pulmonary disease: a neglected entity?Respirology201217690891222845669
  • DadvandPNieuwenhuijsenMJAgustíÀAir pollution and biomarkers of systemic inflammation and tissue repair in COPD patientsEur Respir J201444360361324558180
  • AngelisNPorpodisKZarogoulidisPAirway inflammation in chronic obstructive pulmonary diseaseJ Thorac Dis20146Suppl 1S167S17224672691
  • Chang-ZhengWUnderstanding COPD inflammation: we need to know more about itChin J Respir Crit Care Med200985415417 Available from: http://www.cjrccm.com/article/zghxywzjhzz/2009/5/415Accessed feberuary 02, 2018
  • HanJDaiLZhongNYoungDBreathlessness or health status in chronic obstructive pulmonary disease: the impact of different definitionsCOPD201512211512525474373
  • OpalSMDePaloVAAnti-inflammatory cytokinesChest200011741162117210767254
  • DinarelloCAProinflammatory cytokinesChest2000118250350810936147
  • HoggJCChuFUtokaparchSThe nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med2004350262645265315215480
  • CasanovaCMarinJMMartinez-GonzalezCDifferential effect of modified medical research council dyspnea, COPD assessment test, and clinical COPD questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPDChest2015148115916825612228
  • NishimuraKIzumiTTsukinoMOgaTDyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPDChest200212151434144012006425
  • de TorresJPMarinJMMartinez-GonzalezCCOPD History Assessment in Spain (CHAIN) CohortClinical application of the COPD assessment test: longitudinal data from the COPD History Assessment in Spain (CHAIN) cohortChest2014146111112224522636
  • CasanovaCMarinJMMartinez-GonzalezCCOPD History Assessment In SpaiN (CHAIN) CohortNew GOLD classification: longitudinal data on group assignmentRespir Res201415324417879
  • JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
  • VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
  • HuangWCWuMFChenHCHsuJYTOLD GroupFeatures of COPD patients by comparing CAT with mMRC: a retrospective, cross-sectional studyNPJ Prim Care Respir Med2015251506326538368
  • ZhangRTanXHeQComparison of symptom and risk assessment methods among patients with chronic obstructive pulmonary diseaseChin Med J (Engl)2014127142594259825043073